ARHGAP9 and retinoblastoma: The above results from clinical validation further convinced us to conduct research on ARHGAP9 identified from the transcriptomic data using the in vitro resistant cell line model in the present study, confirming that ARHGAP9 may indeed play an important role in RB chemoresistance [42].